J. Januzzi

Troponin testing after cardiac surgery.

J. Januzzi, J. Januzzi, 2009, HSR proceedings in intensive care & cardiovascular anesthesia.

Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial.

José Miguel Contreras, G. Lip, J. De Sutter, 2021, The lancet. Diabetes & endocrinology.

Prevalence and Impact of Myocardial Injury in Patients Hospitalized with COVID-19 Infection

V. Fuster, Z. Fayad, D. Mancini, 2020, medRxiv.

Cardiac troponin T concentrations above the 99th percentile value as measured by a new high-sensitivity assay predict long-term prognosis in patients with acute coronary syndromes undergoing routine early invasive strategy

E. Giannitsis, J. Januzzi, K. Wollert, 2011, Clinical Research in Cardiology.

Diagnostic and prognostic performance of a novel high-sensitivity cardiac troponin T assay compared to a contemporary sensitive cardiac troponin I assay in patients with acute coronary syndrome

H. Katus, E. Giannitsis, J. Januzzi, 2012, Clinical Research in Cardiology.